According to the latest report by IMARC Group, titled "Optogenetics Market Report by Light Equipment Type (Light-emitting Diode (LED), Laser), Application (Neuroscience, Behavioral Tracking, Retinal Disease Treatment, and Others), End User (Hospitals, Clinics, Diagnostic, Research, and Others), and Region 2025-2033," the global optogenetics market reached a value of USD 51.4 Billion in 2024. Optogenetics is a biological technique that uses a combination of light and genetic engineering to control the cells of the brain. It has become prevalent and is now used in brain research laboratories worldwide. Optogenetics is a neuromodulator method that uses a combination of optics and genetics techniques to control individual neurons' activities in living tissue, even within freely-moving animals. There have been rapid advances in optogenetics, including the advent of wireless microchips, that might aid in providing a suitable treatment option for depression and Parkinson's.
Global Optogenetics Market Trends:
The global market is primarily driven by the increasing prevalence of neurological disorders. In line with this, rapid technological advances in the healthcare sector are creating a positive outlook for the market. Furthermore, extensive research and development (R&D) in the field of optogenetics are positively influencing the market. Apart from this, continual improvements and technical developments in toolsets, such as neural connectivity, neural recording, imaging tools, and cell phenotyping tools, are catalyzing the demand for optogenetics in neuroscience. Moreover, a strong focus on testing novel therapies for cardiac abnormalities is propelling the market. Besides this, the rising geriatric population with vision-related disorders is strengthening the market. Additionally, the growing number of people affected by addiction, mood disorders, depression, and anxiety is providing a boost to the market. Looking forward, the market value is projected to reach USD 177.9 Billion by 2033, expanding at a CAGR of 14.06% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Light Equipment Type, Application, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Addgene, Coherent Inc., Elliot Scientific Limited, GenSight Biologics S.A., HÜBNER GmbH & Co KG, Judges Scientific plc, Laserglow Technologies, Noldus Information Technology, Regenxbio Inc., Shanghai Laser & Optics Century Co. Ltd, The Jackson Laboratory and Thorlabs Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800